Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Gauthier

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
International Clinical Psychopharmacology|July 1, 1987
First clinical experience with ifoxetine, a new 5-HT reuptake blocker with particular emphasis on the side-effect profile of the 5-HT-uptake inhibiting drugsA Delini-Stula, R Fischbach, J M Gauthier, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2001
c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activityM Pessah, C Prunier, J Marais, et al.
Therapie|March 1, 1993
[Work loss and depression. Impact of fluoxetine]E Souetre, H Lozet, P Martin, et al.
Hepatology (Baltimore, Md.)|September 25, 1999
Expression of connective tissue growth factor in experimental rat and human liver fibrosisV Paradis, D Dargere, M Vidaud, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 1, 1997
Characterization of a new human liver myofibroblast cell line: transcriptional regulation of plasminogen activator inhibitor type I by transforming growth factor beta 1F X Weill, S Blazejewski, J F Blanc, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
International Clinical Psychopharmacology|July 1, 1987
First clinical experience with ifoxetine, a new 5-HT reuptake blocker with particular emphasis on the side-effect profile of the 5-HT-uptake inhibiting drugsA Delini-Stula, R Fischbach, J M Gauthier, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2001
c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activityM Pessah, C Prunier, J Marais, et al.
Therapie|March 1, 1993
[Work loss and depression. Impact of fluoxetine]E Souetre, H Lozet, P Martin, et al.
Hepatology (Baltimore, Md.)|September 25, 1999
Expression of connective tissue growth factor in experimental rat and human liver fibrosisV Paradis, D Dargere, M Vidaud, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 1, 1997
Characterization of a new human liver myofibroblast cell line: transcriptional regulation of plasminogen activator inhibitor type I by transforming growth factor beta 1F X Weill, S Blazejewski, J F Blanc, et al.
Pageof 3